Thoratec HeartMate II® left ventricular assist device implantation in patient with patent ventriculoperitoneal shunt

Kentaro Yamane, Linda J. Bogar, Shigeki Tabata, Hitoshi Hirose

Research output: Contribution to journalArticle

Abstract

We report a case of HeartMate II® left ventricular assist device (LVAD) implantation as a destination therapy in a patient with a patent ventriculoperitoneal (VP) shunt after being suffered from subarachnoid hemorrhage. Because the patient's VP shunt was running through her right anterior chest and abdominal wall, a driveline exit site was selected in her left upper quadrant to avoid unnecessary perioperative complication in relation to the patent VP shunt tube. Tailored driveline placement was a key element of this LVAD implantation in this already sick patient with multiple comorbidities.

Original languageEnglish (US)
Pages (from-to)366-369
Number of pages4
JournalAnnals of Thoracic and Cardiovascular Surgery
Volume18
Issue number4
DOIs
StatePublished - Nov 23 2012

Fingerprint

Ventriculoperitoneal Shunt
Heart-Assist Devices
Abdominal Wall
Thoracic Wall
Subarachnoid Hemorrhage
Comorbidity
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Gastroenterology

Cite this

@article{8a66d177b30e41b2913be1a7ebd70063,
title = "Thoratec HeartMate II{\circledR} left ventricular assist device implantation in patient with patent ventriculoperitoneal shunt",
abstract = "We report a case of HeartMate II{\circledR} left ventricular assist device (LVAD) implantation as a destination therapy in a patient with a patent ventriculoperitoneal (VP) shunt after being suffered from subarachnoid hemorrhage. Because the patient's VP shunt was running through her right anterior chest and abdominal wall, a driveline exit site was selected in her left upper quadrant to avoid unnecessary perioperative complication in relation to the patent VP shunt tube. Tailored driveline placement was a key element of this LVAD implantation in this already sick patient with multiple comorbidities.",
author = "Kentaro Yamane and Bogar, {Linda J.} and Shigeki Tabata and Hitoshi Hirose",
year = "2012",
month = "11",
day = "23",
doi = "10.5761/atcs.cr.11.01792",
language = "English (US)",
volume = "18",
pages = "366--369",
journal = "Annals of Thoracic and Cardiovascular Surgery",
issn = "1341-1098",
publisher = "Japanese Association for Coronary Artery Surgery",
number = "4",

}

Thoratec HeartMate II® left ventricular assist device implantation in patient with patent ventriculoperitoneal shunt. / Yamane, Kentaro; Bogar, Linda J.; Tabata, Shigeki; Hirose, Hitoshi.

In: Annals of Thoracic and Cardiovascular Surgery, Vol. 18, No. 4, 23.11.2012, p. 366-369.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Thoratec HeartMate II® left ventricular assist device implantation in patient with patent ventriculoperitoneal shunt

AU - Yamane, Kentaro

AU - Bogar, Linda J.

AU - Tabata, Shigeki

AU - Hirose, Hitoshi

PY - 2012/11/23

Y1 - 2012/11/23

N2 - We report a case of HeartMate II® left ventricular assist device (LVAD) implantation as a destination therapy in a patient with a patent ventriculoperitoneal (VP) shunt after being suffered from subarachnoid hemorrhage. Because the patient's VP shunt was running through her right anterior chest and abdominal wall, a driveline exit site was selected in her left upper quadrant to avoid unnecessary perioperative complication in relation to the patent VP shunt tube. Tailored driveline placement was a key element of this LVAD implantation in this already sick patient with multiple comorbidities.

AB - We report a case of HeartMate II® left ventricular assist device (LVAD) implantation as a destination therapy in a patient with a patent ventriculoperitoneal (VP) shunt after being suffered from subarachnoid hemorrhage. Because the patient's VP shunt was running through her right anterior chest and abdominal wall, a driveline exit site was selected in her left upper quadrant to avoid unnecessary perioperative complication in relation to the patent VP shunt tube. Tailored driveline placement was a key element of this LVAD implantation in this already sick patient with multiple comorbidities.

UR - http://www.scopus.com/inward/record.url?scp=84869209062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869209062&partnerID=8YFLogxK

U2 - 10.5761/atcs.cr.11.01792

DO - 10.5761/atcs.cr.11.01792

M3 - Article

C2 - 22293312

AN - SCOPUS:84869209062

VL - 18

SP - 366

EP - 369

JO - Annals of Thoracic and Cardiovascular Surgery

JF - Annals of Thoracic and Cardiovascular Surgery

SN - 1341-1098

IS - 4

ER -